# Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

> **NCT04069325** · NA · UNKNOWN · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 72 (estimated)

## Conditions studied

- Gout Flare

## Interventions

- **DRUG:** simiaowan
- **DRUG:** placebo
- **DRUG:** febuxostat

## Key facts

- **NCT ID:** NCT04069325
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2020-07-28
- **Final completion:** 2020-07-28
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2019-08-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04069325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04069325, "Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04069325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*